NasdaqCM:BLFSLife Sciences
A Look At BioLife Solutions (BLFS) Valuation After New Qkine Cell And Gene Therapy Partnership
BioLife Solutions (BLFS) shares are in focus after the company entered a multi year supply agreement with Qkine Limited. The deal secures exclusive worldwide distribution rights to selected cytokine and growth factor products for cell and gene therapy manufacturing.
See our latest analysis for BioLife Solutions.
Despite the Qkine agreement, BioLife Solutions’ share price return has been mixed, with a 7 day gain of 3.87% but a 30 day and year to date share price decline. The 1 year total...